293 related articles for article (PubMed ID: 34772471)
1. DrugEx v2: de novo design of drug molecules by Pareto-based multi-objective reinforcement learning in polypharmacology.
Liu X; Ye K; van Vlijmen HWT; Emmerich MTM; IJzerman AP; van Westen GJP
J Cheminform; 2021 Nov; 13(1):85. PubMed ID: 34772471
[TBL] [Abstract][Full Text] [Related]
2. DrugEx v3: scaffold-constrained drug design with graph transformer-based reinforcement learning.
Liu X; Ye K; van Vlijmen HWT; IJzerman AP; van Westen GJP
J Cheminform; 2023 Feb; 15(1):24. PubMed ID: 36803659
[TBL] [Abstract][Full Text] [Related]
3. An exploration strategy improves the diversity of de novo ligands using deep reinforcement learning: a case for the adenosine A
Liu X; Ye K; van Vlijmen HWT; IJzerman AP; van Westen GJP
J Cheminform; 2019 May; 11(1):35. PubMed ID: 31127405
[TBL] [Abstract][Full Text] [Related]
4. FSM-DDTR: End-to-end feedback strategy for multi-objective De Novo drug design using transformers.
Monteiro NRC; Pereira TO; Machado ACD; Oliveira JL; Abbasi M; Arrais JP
Comput Biol Med; 2023 Sep; 164():107285. PubMed ID: 37557054
[TBL] [Abstract][Full Text] [Related]
5. Faster and more diverse de novo molecular optimization with double-loop reinforcement learning using augmented SMILES.
Bjerrum EJ; Margreitter C; Blaschke T; Kolarova S; de Castro RL
J Comput Aided Mol Des; 2023 Aug; 37(8):373-394. PubMed ID: 37329395
[TBL] [Abstract][Full Text] [Related]
6. Diversity oriented Deep Reinforcement Learning for targeted molecule generation.
Pereira T; Abbasi M; Ribeiro B; Arrais JP
J Cheminform; 2021 Mar; 13(1):21. PubMed ID: 33750461
[TBL] [Abstract][Full Text] [Related]
7. Magicmol: a light-weighted pipeline for drug-like molecule evolution and quick chemical space exploration.
Chen L; Shen Q; Lou J
BMC Bioinformatics; 2023 Apr; 24(1):173. PubMed ID: 37101113
[TBL] [Abstract][Full Text] [Related]
8. DrugEx: Deep Learning Models and Tools for Exploration of Drug-Like Chemical Space.
Šícho M; Luukkonen S; van den Maagdenberg HW; Schoenmaker L; Béquignon OJM; van Westen GJP
J Chem Inf Model; 2023 Jun; 63(12):3629-3636. PubMed ID: 37272707
[TBL] [Abstract][Full Text] [Related]
9. Status and Prospects of Research on Deep Learning-based De Novo Generation of Drug Molecules.
Shi H; Wang Z; Zhou L; Xu Z; Xie L; Kong R; Chang S
Curr Comput Aided Drug Des; 2024 Feb; ():. PubMed ID: 38321907
[TBL] [Abstract][Full Text] [Related]
10. De novo drug design based on Stack-RNN with multi-objective reward-weighted sum and reinforcement learning.
Hu P; Zou J; Yu J; Shi S
J Mol Model; 2023 Mar; 29(4):121. PubMed ID: 36991180
[TBL] [Abstract][Full Text] [Related]
11. Designing optimized drug candidates with Generative Adversarial Network.
Abbasi M; Santos BP; Pereira TC; Sofia R; Monteiro NRC; Simões CJV; Brito RMM; Ribeiro B; Oliveira JL; Arrais JP
J Cheminform; 2022 Jun; 14(1):40. PubMed ID: 35754029
[TBL] [Abstract][Full Text] [Related]
12. Computer-aided multi-objective optimization in small molecule discovery.
Fromer JC; Coley CW
Patterns (N Y); 2023 Feb; 4(2):100678. PubMed ID: 36873904
[TBL] [Abstract][Full Text] [Related]
13. Memory-assisted reinforcement learning for diverse molecular de novo design.
Blaschke T; Engkvist O; Bajorath J; Chen H
J Cheminform; 2020 Nov; 12(1):68. PubMed ID: 33292554
[TBL] [Abstract][Full Text] [Related]
14. Deep reinforcement learning for de novo drug design.
Popova M; Isayev O; Tropsha A
Sci Adv; 2018 Jul; 4(7):eaap7885. PubMed ID: 30050984
[TBL] [Abstract][Full Text] [Related]
15. Improving drug discovery with a hybrid deep generative model using reinforcement learning trained on a Bayesian docking approximation.
Xiong Y; Wang Y; Wang Y; Li C; Yusong P; Wu J; Wang Y; Gu L; Butch CJ
J Comput Aided Mol Des; 2023 Nov; 37(11):507-517. PubMed ID: 37550462
[TBL] [Abstract][Full Text] [Related]
16. De novo drug design as GPT language modeling: large chemistry models with supervised and reinforcement learning.
Ye G
J Comput Aided Mol Des; 2024 Apr; 38(1):20. PubMed ID: 38647700
[TBL] [Abstract][Full Text] [Related]
17. De novo generation of dual-target ligands using adversarial training and reinforcement learning.
Lu F; Li M; Min X; Li C; Zeng X
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34410338
[TBL] [Abstract][Full Text] [Related]
18. Adversarial Threshold Neural Computer for Molecular de Novo Design.
Putin E; Asadulaev A; Vanhaelen Q; Ivanenkov Y; Aladinskaya AV; Aliper A; Zhavoronkov A
Mol Pharm; 2018 Oct; 15(10):4386-4397. PubMed ID: 29569445
[TBL] [Abstract][Full Text] [Related]
19. De Novo Molecule Design by Translating from Reduced Graphs to SMILES.
Pogány P; Arad N; Genway S; Pickett SD
J Chem Inf Model; 2019 Mar; 59(3):1136-1146. PubMed ID: 30525594
[TBL] [Abstract][Full Text] [Related]
20. A Pareto Algorithm for Efficient De Novo Design of Multi-functional Molecules.
Daeyaert F; Deem MW
Mol Inform; 2017 Jan; 36(1-2):. PubMed ID: 28124835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
